Australian Biotechnology News

Stories about: GlaxoSmithKline

  • +

    Monash University professor receives GSK Australia Award for Research 18/08/2010 09:38:00

    This year’s prestigious GlaxoSmithKline Australia Award for Research has gone to Monash University’s Professor Charles Mackay for his work on immunology and inflammation, particularly the discovery of GPR43 as a major regulator of innate and inflammatory response.
  • +

    Melanoma cases to double over next decade 23/06/2010 18:32:00

    The number of melanoma cases will double over the next 10 years, presenting attractive opportunities for drug companies to improve on existing poor and outdated standards of treatment.
  • +

    Glaxo’s asthma market lead to run out of puff 24/05/2010 17:29:00

    GlaxoSmithKline will see its dominance of the Australian asthma treatment market eroded over the next few years by the arrival of new combination and generic products. That’s according to a new study from industry analysts Datamonitor .
  • +

    BIO 2010: Australian biotech, state of the nation 04/05/2010 08:40:00

    It’s not just the Big Three – CSL,ResMed and Cochlear – with high hopes for 2010. Many other Australian biotechnology companies are either in the final stages of trials and are close to gaining regulatory approval, or they are in the initial stages of commercialising their products, with several forming strategic partnerships to expand into new and lucrative overseas markets.
  • +

    Diabetes market growing, obesity market shrinking: analysts 10/03/2010 12:16:00

    Datamonitor Group predicts antidiabetics market will continue to expand, but obesity plagued by perception and treatment issues.
  • +

    Killer cells could cure cancer 17/06/2009 17:08:00

    Australian researchers close to a breakthrough in cancer treatment using the body's own immune system to destroy cancerous cells.
  • +

    Philip Hogg awarded NSW's top cancer research gong 22/05/2009 07:12:00

    The Cancer Institute NSW Premier's Award for Outstanding Cancer Researcher
  • +

    Generic opportunity for Alchemia 13/03/2009 14:47:00

    Alchemia’s partner files generic application for fondaparinux
  • +

    BIO 2008: Waking up to sleeping sickness 06/06/2008 11:32:51

    WA company Epichem and the Drugs for Neglected Diseases initiative are collaborating to develop new drugs to treat African sleeping sickness and similar, forgotten diseases.
  • +

    More twists to Avandia saga 31/01/2008 12:40:39

    Nature reports that a peer reviewer leaked an unfavourable report on diabetes drug Avandia to manufacturer.
  • +

    Thanks from the research community 20/11/2007 12:17:56

    The annual Research Australia Thank You Day awards have been announced.
Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
 
Jobs